All News #Library
Others
QHP Launches $1.1B Fund For Azurity Pharmaceuticals
18 Mar 2026 //
PHARMIWEB
George Medicines, Biolab Sign Deal for GMRx2 Commercialization
02 Oct 2025 //
GLOBENEWSWIRE
Azurity telegraphs 75 layoffs as MA plant closure looms
14 Jul 2025 //
FIERCE PHARMA
FDA Approves XIFYRM (Meloxicam Injection) for Pain In Adults
10 Jun 2025 //
PR NEWSWIRE
Jerome Stevens Pharmaceuticals Acquires Thyquidity®
01 Apr 2025 //
BUSINESSWIRE
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
14 Mar 2025 //
PR NEWSWIRE
Azurity Announces Launch Of Azmiro Injection
12 Dec 2024 //
PR NEWSWIRE
Azurity scores FDA nod for new formulation of Novartis` Tasigna
16 Nov 2024 //
FIERCE PHARMA
Azurity Pharma Announces FDA Approval of Danziten Tablets
14 Nov 2024 //
PR NEWSWIRE
Azurity Pharmaceuticals Announces FDA Approval of Nymalize Oral Solution
03 Sep 2024 //
PR NEWSWIRE
Azurity Pharmaceuticals` MYHIBBIN™ gets FDA approval.
06 May 2024 //
PR NEWSWIRE
Azurity Pharmaceuticals Acquires Slayback Pharma
27 Sep 2023 //
PR NEWSWIRE
Brand Institute Partners for FDA Approved Treatment for Gastric Ulcer
07 Sep 2022 //
PRNEWSWIRE
Azurity continues its win streak as it bags another approval from the FDA
03 Sep 2022 //
ENDPTS
US FDA grants approval for Azurity’s Konvomep to treat gastric ulcer
02 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
AZURITY PHARMA ANNOUNCES FDA APPROVAL OF ZONISADE (zonisamide oral suspension)
18 Jul 2022 //
PRNEWSWIRE
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
18 Feb 2022 //
PRNEWSWIRE
US FDA approves Azurity Pharma’s Fleqsuvy for spasticity from multiple sclerosis
08 Feb 2022 //
PHARMABIZ
FDA approves Eton-Azurity’s Eprontia oral solution for seizures and migraines
09 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
Eton Pharma and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™
08 Nov 2021 //
GLOBENEWSWIRE
AZURITY ANNOUNCES FDA APPROVAL OF EPRONTIA oral solution
08 Nov 2021 //
PRNEWSWIRE

Market Place
Sourcing Support